When the new warning is issued I will post it.
The Food and Drug Administration said Thursday it would add new warnings to packaging for Neurontin, Lyrica and generic versions, which are used to treat seizures, nerve pain, restless leg syndrome and other conditions.
The new labels will warn doctors against prescribing the drugs with other medications that can slow breathing, including opioid painkillers. The breathing risks also apply to elderly patients and those with existing lung problems.
The medications, known generically as gabapentin and pregabalin, are among the most prescribed in the U.S. Both physician prescribing and misuse have increased as doctors, hospitals and other health care providers have scaled back their use of opioids amid a national epidemic.
Poison control centers have reported increased calls involving the nerve drugs, which are often abused in combination with opioids, cocaine and marijuana. Neurontin and related generics have long been considered nonaddictive and are not tracked as closely by regulators.